Download Files:
α7 Nicotinic receptor agonist-1
$320 – $2,700
Products Details
Product Description
– α7 Nicotinic receptor agonist-1 (Preparation 5) is an α7 nAChR agonist. α7 Nicotinic receptor agonist-1 can be used in studies of psychiatric disorders (such as schizophrenia, manic or hypomanic depression and anxiety disorders) and intellectual disorders (such as alzheimer’s disease, learning deficits, cognitive deficits, attention deficits, memory loss, lewy body dementia and attention deficit hyperactivity disorder)[1].
Web ID
– HY-148325
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Molecular Formula
– C13H17N3O
References
– [1]James Loch Iii, et al. Novel aralkyl amines of spirofuropyridines useful in therapy. Patent WO2000042044A1.
CAS Number
– 220100-05-0
Molecular Weight
– 231.29
Compound Purity
– 99.74
SMILES
– NC1=CN=C2OC3(CC2=C1)C(CC4)CCN4C3
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– nAChR
Pathway
– Membrane Transporter/Ion Channel;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
